Loading company…
Oncoprecision develops therapeutic antibodies and patient-derived models for oncology.
Oncoprecision's pipeline includes an antibody-drug conjugate for monocytic leukemia and a bispecific antibody targeting tumor-associated macrophages. It works with pharmaceutical partners and cancer research institutions. Founded in 2020, the company is based in New York, US. It has raised USD 3.3 mn in Seed funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in